Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.
Alberto J EspayRobert A HauserRohit DhallSandeep ThakkarLeslie CloudLeonid ZeitlinGhazal BanisadrStanley FisherHester VisserPublished in: Movement disorders : official journal of the Movement Disorder Society (2023)
In this phase 3 open-label extension, IPX203 exhibited a favorable safety and tolerability profile and sustained efficacy of comparable magnitude to the end of the double-blind study. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.